Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-23-002133

Director sold 9,671 shares at $76.82 ($742,942)

  • Director acquired 9,671 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

STONE HEISZ LESLIE · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-02-16 Exercise or conversion : show line 1 in the form +9,671 $35.68 $345,029 37,151 D
2023-02-16 Sale : show line 2 in the form −9,671 $76.82 $742,942 27,480 D
Open-market sales · 9,671 sh · avg $76.82 · $742,942

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-02-16 Exercise or conversion : show line 3 in the form Director Stock Option (Right to Acquire) −9,671 $35.68 2023-07-13 9,671 0 D
Loading xslF345X03/doc4.xml…